113 related articles for article (PubMed ID: 3757164)
1. The effect of food on the oral administration of 6-mercaptopurine.
Burton NK; Barnett MJ; Aherne GW; Evans J; Douglas I; Lister TA
Cancer Chemother Pharmacol; 1986; 18(1):90-1. PubMed ID: 3757164
[TBL] [Abstract][Full Text] [Related]
2. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
Riccardi R; Balis FM; Ferrara P; Lasorella A; Poplack DG; Mastrangelo R
Pediatr Hematol Oncol; 1986; 3(4):319-24. PubMed ID: 3153245
[TBL] [Abstract][Full Text] [Related]
3. Oral mercaptopurine in childhood leukemia: influence of food intake on bioavailability.
Lönnerholm G; Kreuger A; Lindström B; Myrdal U
Pediatr Hematol Oncol; 1989; 6(2):105-12. PubMed ID: 2702064
[TBL] [Abstract][Full Text] [Related]
4. The effect of methotrexate on the bioavailability of oral 6-mercaptopurine.
Balis FM; Holcenberg JS; Zimm S; Tubergen D; Collins JM; Murphy RF; Gilchrist GS; Hammond D; Poplack DG
Clin Pharmacol Ther; 1987 Apr; 41(4):384-7. PubMed ID: 3470165
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of orally administered chemotherapy. A reappraisal.
Poplack DG; Balis FM; Zimm S
Cancer; 1986 Jul; 58(2 Suppl):473-80. PubMed ID: 3459570
[TBL] [Abstract][Full Text] [Related]
6. The effect of cotrimoxazole on the absorption of orally administered 6-mercaptopurine in the rat.
Burton NK; Aherne GW
Cancer Chemother Pharmacol; 1986; 16(1):83-4. PubMed ID: 3484383
[TBL] [Abstract][Full Text] [Related]
7. Plasma and erythrocyte concentrations of mercaptopurine after oral administration in children.
Lönnerholm G; Kreuger A; Lindström B; Ludvigsson J; Myrdal U
Pediatr Hematol Oncol; 1986; 3(1):27-35. PubMed ID: 3153216
[TBL] [Abstract][Full Text] [Related]
8. Rectal bioavailability of 6-mercaptopurine in children with acute lymphoblastic leukaemia: partial avoidance of "first-pass" metabolism.
Kato Y; Matsushita T; Uchida H; Egi S; Yokoyama T; Mohri K
Eur J Clin Pharmacol; 1992; 42(6):619-22. PubMed ID: 1623901
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral 6-mercaptopurine: relationship between plasma levels and urine excretion of parent drug.
Endresen L; Lie SO; Storm-Mathisen I; Rugstad HE; Stokke O
Ther Drug Monit; 1990 May; 12(3):227-34. PubMed ID: 2349605
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol.
Zimm S; Collins JM; O'Neill D; Chabner BA; Poplack DG
Clin Pharmacol Ther; 1983 Dec; 34(6):810-7. PubMed ID: 6580097
[TBL] [Abstract][Full Text] [Related]
11. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
12. Serum azathioprine and 6-mercaptopurine levels and immunosuppressive activity after azathioprine in uremic patients.
Odlind B; Hartvig P; Lindström B; Lönnerholm G; Tufveson G; Grefberg N
Int J Immunopharmacol; 1986; 8(1):1-11. PubMed ID: 3957504
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia.
Lafolie P; Hayder S; Björk O; Peterson C
Eur J Clin Pharmacol; 1991; 40(6):599-601. PubMed ID: 1884741
[TBL] [Abstract][Full Text] [Related]
14. Absolute bioavailability of imipramine: influence of food.
Abernethyl DR; Divoll M; Greenblatt DJ; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1984; 83(1):104-6. PubMed ID: 6429693
[TBL] [Abstract][Full Text] [Related]
15. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
Landier W; Hageman L; Chen Y; Kornegay N; Evans WE; Bostrom BC; Casillas J; Dickens DS; Angiolillo AL; Lew G; Maloney KW; Mascarenhas L; Ritchey AK; Termuhlen AM; Carroll WL; Relling MV; Wong FL; Bhatia S
J Clin Oncol; 2017 May; 35(15):1730-1736. PubMed ID: 28339328
[TBL] [Abstract][Full Text] [Related]
16. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.
Cuffari C; Théorêt Y; Latour S; Seidman G
Gut; 1996 Sep; 39(3):401-6. PubMed ID: 8949645
[TBL] [Abstract][Full Text] [Related]
17. The temporal effect of food on tacrine bioavailability.
Welty DF; Siedlik PH; Posvar EL; Selen A; Sedman AJ
J Clin Pharmacol; 1994 Oct; 34(10):985-8. PubMed ID: 7836549
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.
Lennard L; Lilleyman JS; Van Loon J; Weinshilboum RM
Lancet; 1990 Jul; 336(8709):225-9. PubMed ID: 1973780
[TBL] [Abstract][Full Text] [Related]
19. The effect of food on oral melphalan absorption.
Reece PA; Kotasek D; Morris RG; Dale BM; Sage RE
Cancer Chemother Pharmacol; 1986; 16(2):194-7. PubMed ID: 3948305
[TBL] [Abstract][Full Text] [Related]
20. The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule.
Yun HY; Joo Lee E; Youn Chung S; Choi SO; Kee Kim H; Kwon JT; Kang W; Kwon KI
Clin Pharmacokinet; 2006; 45(4):425-32. PubMed ID: 16584288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]